Effect of a garlic derivative (alliin) on peripheral blood cell immune responses

International Journal of Immunopharmacology

Volumn 21, Issue 9, 1999, Pages 589-597

  Salman, Hertzel ^a,b   Bergman, Michael ^a,b   Bessler, Hanna ^a   Punsky, Igor ^a   Djaldetti, Meir ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alliin; Cytokines; Garlic; Phagocytosis

Indexed keywords

ALLIIN; CONCANAVALIN A; CYTOKINE; INODAIL; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GARLIC; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOMODULATION; MONONUCLEAR CELL; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

BLOOD CELLS; CYSTEINE; CYTOKINES; HUMANS; LEUKOCYTES; MITOGENS; MONOCYTES; PHAGOCYTOSIS; SUPEROXIDES;

EID: 0032817467     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00038-7     Document Type: Article

References (28)

1. Agarwal K.C. Therapeutic actions of garlic constituents. Med. Res. Rev. 16:1996;111-124.
2. Augusti K.T. Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian J. Exp. Biol. 34:1996;634-640.
3. Geng Z., Rong Y., Lau B.H. S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells. Free Radic. Biol. Med. 23:1997;345-350.
4. Hellstrand K., Hermodsson S. Interleukin-2 can induce suppression of human natural killer cell cytotoxicity. Clin. Exp. Immunol. 7:1989;410-416.
5. Isaacsohn J.L., Moser M., Stein E.A., Dudley K., Davey J.A., Liskov E., Black H.R. Garlic powder and plasma lipids and lipoproteins. A multicenter, randomized, placebo-controlled trial. Arch. Int. Med. 158:1998;1189-1194.
6. Johnston R.B., Godzik C.A., Cohn Z.A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J. Exp. Med. 148:1978;115-127.
7. Kiesewetter H., Jung F., Jung E.M., Mroweitz C., Koscielny J., Wenzel E. Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischemic attack. Eur. J. Clin. Pharmacol. 45:1993;333-336.
8. Kiesewetter H., Jung F., Pindur G., Jung E.M., Mroweitz C., Wenzel E. Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int. J. Clin. Pharmacol. Ther. Toxicol. 29:1991;151-155.
9. Komlos L., Ben-Efraim S., Notmann J., Hart J., Halbrecht I. Difference in sensitivity to melphalan between ConA-activated and nonactivated human T-cell subsets. Clin. Immunol. Immunopathol. 45:1987;105-113.
10. Kourounakis P.N., Rekka E.A. Effect of active oxygen species of alliin and Allium sativum (garlic) powder. Res. Commun. Chem. Pathol, Pharmacol. 74:1991;249-252.
11. 35 labeled garlic constituents alliin, allicin and vinyldithine. Arzneimittelforshung. 44:1994;734-743.
12. Lau B.H., Yamasaki T., Gridley D.C. Garlic compounds modulate macrophage and T-lymphocyte function. Mol. Biother. 3:1991;103-107.
13. Lydyard P.M., Hayward A.R. Induction of suppression through human T cell interactions. Clin. Exp. Immunol. 39:1979;496-502.
14. McMahon F.G., Vargas R. Can garlic lower blood pressure? A pilot study. Pharmacotherapy. 13:1993;406-407.
15. Milner J.A. Garlic: its anticarcinogenic and antitumorigenic properties. Nutr. Rev. 54:1996;S82-S86.
16. Moore K., Nesbitt A.M. Identification and isolation of OKT4+suppressor cells with the monoclonal antibody WR16. Immunology. 58:1986;659-664.
17. Morioka N., Sze L.L., Morton D.L., Irie R.F. A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A. Cancer Immunol. Immunother. 37:1993;316-322.
18. Numagami Y., Sato S., Ohnishi S.T. Attenuation of rat ischemic brain damage by aged garlic extracts: a possible protecting mechanism as antioxidants. Neurochem. Int. 29:1996;135-143.
19. Orekhov A.N., Tertov V.V., Sobenin I.A., Pivovarova E.M. Direct anti-atherosclerosis-related effects of garlic. Ann. Med. 27:1995;63-65.
20. Phelps S., Harris W.S. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids. 28:1993;475-477.
21. Prasad K., Laxdal V.A., Yu M., Raney B.L. Antioxidant activity of allicin, an active principle in garlic. Mol. Cell Biochem. 148:1995;183-189.
22. Rabinkov A., Miron T., Konstantinovski L., Wilchek M., Mirelman D., Weiner L. The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim. Biophys. Acta. 1379:1998;233-244.
23. Resch K.L., Ernst E. Garlic (Allium sativum)-a potent medicinal plant. J. Fortschr. Med. 113:1995;311-315.
24. Romano E.L., Montano R.F., Brito B., Apitz R., Alonso J., Romano M., Gebran S., Soyano A. Effect of Ajoene on lymphocyte and macrophage membrane-dependent functions. Immunopharmacol. Immunotoxicol. 19:1997;15-36.
25. Simons L.A., Balasubramaniam S., von-Konigsmark M., Parfitt A., Simons J., Peters W. On the effect of garlic on plasma lipids and lipoprotein in mild hypercholesterolemia. Atherosclerosis. 113:1995;219-225.
26. Sumiyoshi H. New pharmacological activities of garlic and its constituents. Nippon Yakurigaku Sasshi. 110:(1):1997;93-97.
27. Uchiyama T., Broder S., Waldmann T.A. Monoclonal antibody (anti Tac) reactive with activated and functionally mature T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol. 126:1981;1393-1397.
28. Uchiyama T., Nelson D.L., Fleisher T.A., Waldmann T.A. Monoclonal antibody (anti Tac) reactive with activated and functionally mature T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and one of two types of helper T cells. J. Immunol. 126:1981;1398-1403.